4 European Projects Found
Searched on 125080 European Projects
FINISHED
Divided Metacognition: when epistemic norms conflict (DIVIDNORM)
Start date: Jul 1, 2011, End date: Dec 31, 2016,
The present project aims to provide a naturalistic account of epistemic norms, and of the associated epistemic awareness in children and adults from different cultures. Epistemics norms (ENs) such as intelligibility, relevance, truth, coherence and consensus are dimensions on which mental contents can be evaluated for their contribution to knowledge acquisition. Although EN sensitivity is central ...
Read Project
4
Partners Participants
FINISHED
Persistence of allergic sensitization (PAS)
Start date: Dec 1, 2009, End date: Nov 30, 2014,
"Allergic disorders are dramatically increasing in the western world over the past several years. Allergies are inappropriate immune responses directed against harmless environmental antigens. Upon primary allergen encounter B cells are induced to differentiate into IgE producing plasma cells. Mast cells and basophils are then sensitized by binding of allergen-specific IgE molecules to the high-af ...
Read Project
2
Partners Participants
FINISHED
Euro-BioImaging - Research infrastructure for imaging technologies in biological and biomedical sciences (Euro-BioImaging)
Start date: Dec 1, 2010, End date: May 31, 2014,
Euro-BioImaging brings together imaging technologies stretching from basic biological imaging with advanced light microscopy, in vivo molecular imaging of single cells to animal models up to the clinical and epidemiological level of medical imaging of humans and populations. Euro-BioImaging, in close consultation with its stakeholders, will address the imaging requirements of both biological and m ...
Read Project
44
Partners Participants
FINISHED
Memory loss in Alzheimer disease: underlying mechanisms and therapeutic targets (MEMOSAD)
Start date: Jan 1, 2008, End date: Jun 30, 2011,
"MEMOSAD aims at defining the molecular mechanisms of Abeta- and Tau-induced synaptotoxicity and at developing disease-modifying therapeutics for the prevention of memory loss in Alzheimer disease (AD). Insoluble aggregates of the two proteins provide the pathological hallmarks of this incurable brain disorder. Early stage AD is characterized by a remarkably pure impairment of declarative memory a ...
Read Project
